Coordinated regulation of myeloid cells by tumours

Gabrilovich, Dmitry I., Ostrand-Rosenberg, Suzanne, Bronte, Vincenzo·2012·Nature Reviews Immunology

DOI 10.1038/nri3175

Cited by (131)

Items 101–131 of 131

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
Martens, Alexander, Wistuba-Hamprecht, Kilian, Yuan, Jianda, Postow, Michael A., Wong, Phillip, Capone, Mariaelena, Madonna, Gabriele, Khammari, Amir, Schilling, Bastian, Sucker, Antje et al. · 2016 · Clinical Cancer Research
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Jung, Keehoon, Heishi, Takahiro, Khan, Omar F., Kowalski, Piotr S., Incio, Joao, Rahbari, Nuh N., Chung, Euiheon, Clark, Jeffrey W., Willett, Christopher G., Luster, Andrew D. et al. · 2017 · Journal of Clinical Investigation
Local activation of p53 in the tumor microenvironment overcomes immune suppression and enhances antitumor immunity
Guo, Gang, Yu, Miao, Xiao, Wei, Celis, Esteban, Cui, Yan · 2017 · Cancer Research
T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
Azzaoui, Imane, Uhel, Fabrice, Rossille, Delphine, Pangault, Celine, Dulong, Joelle, Le Priol, Jerome, Lamy, Thierry, Houot, Roch, Le Gouill, Steven, Cartron, Guillaume et al. · 2016 · Blood
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq
Song, Qianqian, Hawkins, Gregory A., Wudel, Leonard, Chou, Ping‐Chieh, Forbes, Elizabeth, Pullikuth, Ashok K., Liu, Liang, Jin, Guangxu, Craddock, Lou, Topaloglu, Umit et al. · 2019 · Cancer Medicine
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Qianyu, Shen, Xiaofei, Chen, Gang, Du, Junfeng · 2022 · Cancers
Myeloid cell heterogeneity in cancer: not a single cell alike
Kiss, Mate, Van Gassen, Sofie, Movahedi, Kiavash, Saeys, Yvan, Laoui, Damya · 2018 · Cellular Immunology
The Tumor Microenvironment: A Pitch for Multiple Players
Schiavoni, Giovanna, Gabriele, Lucia, Mattei, Fabrizio · 2013 · Frontiers in Oncology
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
Wong, Jeffrey Sum Lung, Kwok, Gerry Gin Wai, Tang, Vikki, Li, Bryan Cho Wing, Leung, Roland, Chiu, Joanne, Ma, Ka Wing, She, Wong Hoi, Tsang, Josephine, Lo, Chung Mau et al. · 2021 · Journal for ImmunoTherapy of Cancer
Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion
Zoso, Alessia, Mazza, Emilia M. C., Bicciato, Silvio, Mandruzzato, Susanna, Bronte, Vincenzo, Serafini, Paolo, Inverardi, Luca · 2014 · European Journal of Immunology
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
Mastio, Jérôme, Condamine, Thomas, Dominguez, George, Kossenkov, Andrew V., Donthireddy, Laxminarasimha, Veglia, Filippo, Lin, Cindy, Wang, Fang, Fu, Shuyu, Zhou, Jie et al. · 2019 · Journal of Experimental Medicine
Gemcitabine nanoparticles promote antitumor immunity against melanoma
Zhang, Yuan, Bush, Xin, Yan, Bingfang, Chen, Justin A. · 2019 · Biomaterials
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Lu, Weiqiang, Yu, Weiwei, He, Jiacheng, Liu, Wenjuan, Yang, Junjie, Lin, Xianhua, Zhang, Yuanjin, Wang, Xin, Jiang, Wenhao, Luo, Jian et al. · 2021 · EMBO Molecular Medicine
Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation
Ray, Anuradha, Chakraborty, Krishnendu, Ray, Prabir · 2013 · Frontiers in Cellular and Infection Microbiology
Bimodal CD40/Fas-Dependent crosstalk between iNKT cells and tumor-associated macrophages impairs prostate cancer progression
Cortesi, Filippo, Delfanti, Gloria, Grilli, Andrea, Calcinotto, Arianna, Gorini, Francesca, Pucci, Ferdinando, Lucianò, Roberta, Grioni, Matteo, Recchia, Alessandra, Benigni, Fabio et al. · 2018 · Cell Reports
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
Olsson, Anders, Nakhlé, Jessica, Sundstedt, Anette, Plas, Pascale, Bauchet, Anne-Laure, Pierron, Valérie, Bruetschy, Luce, Deronic, Adnan, Törngren, Marie, Liberg, David et al. · 2015 · Journal for ImmunoTherapy of Cancer
Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells
Varikuti, Sanjay, Singh, Bhawana, Volpedo, Greta, Ahirwar, Dinesh K., Jha, Bijay K., Saljoughian, Noushin, Viana, Agostinho G., Verma, Chaitenya, Hamza, Omar, Halsey, Gregory et al. · 2020 · British Journal of Cancer
Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells
Hong, JongWook, Tobin, Nicholas P., Rundqvist, Helene, Li, Tian, Lavergne, Marion, García-Ibáñez, Yaiza, Qin, Hanyu, Paulsson, Janna, Zeitelhofer, Manuel, Adzemovic, Milena Z. et al. · 2015 · Journal of the National Cancer Institute
T cells encountering myeloid cells programmed for amino acid-dependent immunosuppression use Rictor/mTORC2 protein for proliferative checkpoint decisions
Van de Velde, Lee-Ann, Subramanian, Chitra, Smith, Amber M., Barron, Luke, Qualls, Joseph E., Neale, Geoffrey, Alfonso-Pecchio, Adolfo, Jackowski, Suzanne, Rock, Charles O., Wynn, Thomas A. et al. · 2017 · Journal of Biological Chemistry
Six-color intravital two-photon imaging of brain tumors and their dynamic microenvironment
Ricard, Clément, Debarbieux, Franck Christian · 2014 · Frontiers in Cellular Neuroscience
Analysis of the Expression and Regulation of PD-1 Protein on the Surface of Myeloid-Derived Suppressor Cells (MDSCs)
Nam, Sorim, Lee, Aram, Lim, Jihyun, Lim, Jong-Seok · 2019 · Biomolecules & Therapeutics
A multidisciplinary study using<i>in vivo</i>tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells
Mattei, Fabrizio, Schiavoni, Giovanna, De Ninno, Adele, Lucarini, Valeria, Sestili, Paola, Sistigu, Antonella, Fragale, Alessandra, Sanchez, Massimo, Spada, Massimo, Gerardino, Annamaria et al. · 2014 · Journal of Immunotoxicology
Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
Fotsitzoudis, Charalampos, Koulouridi, Asimina, Messaritakis, Ippokratis, Konstantinidis, Theocharis, Gouvas, Nikolaos, Tsiaoussis, John, Souglakos, John · 2022 · Cancers
Microbiota Modulation of Myeloid Cells in Cancer Therapy
Goldszmid, Romina S., Dzutsev, Amiran, Viaud, Sophie, Zitvogel, Laurence, Restifo, Nicholas P., Trinchieri, Giorgio · 2015 · Cancer Immunology Research
Immunotherapies for pediatric cancer: current landscape and future perspectives
Hutzen, Brian, Paudel, Siddhi Nath, Naeimi Kararoudi, Meisam, Cassady, Kevin A., Lee, Dean A., Cripe, Timothy P. · 2019 · Cancer and Metastasis Reviews
Efferocytosis Creates a Tumor Microenvironment Supportive of Tumor Survival and Metastasis
2015 · Cancer Cell & Microenvironment
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Yuqing, Coleman, Morgan, Brekken, Rolf A. · 2021 · Cancers
Myeloid cell–derived HOCl is a paracrine effector that trans-inhibits IKK/NF-κB in melanoma cells and limits early tumor progression
Liu, Tracy W., Gammon, Seth T., Yang, Ping, Fuentes, David, Piwnica-Worms, David · 2021 · Science Signaling
Immunologic Correlates in the Course of Treatment With Immunomodulating Antibodies
Weide, Benjamin, Di Giacomo, Anna Maria, Fonsatti, Ester, Zitvogel, Laurence · 2015 · Seminars in Oncology
The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesis
Grasso, Francesca, Di Meo, Serena, De Luca, Gabriele, Pasquini, Luca, Rossi, Stefania, Boirivant, Monica, Biffoni, Mauro, Bignami, Margherita, Di Carlo, Emma · 2015 · Oncotarget
Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer
Caronni, Nicoletta, Montaldo, Elisa, Mezzanzanica, Luca, Cilenti, Francesco, Genua, Marco, Ostuni, Renato · 2021 · Immunological Reviews